PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

According to recent guidelines, oral dabigatran etexilate is indicated for stroke and systemic embolism prevention in patients with atrial fibrillation (AF). Aim. Based on the RE-LY study to evaluate the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings f...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
格式: Artigo
語言:Inglês
出版: Stolichnaya Izdatelskaya Kompaniya 2015-12-01
叢編:Racionalʹnaâ Farmakoterapiâ v Kardiologii
主題:
dabigatran etexelate
warfarin
vitamin k antagonists
atrial fibrillation
pharmacoecomomics
clinic-economic evaluation
cost-effectiveness
markov modeling
在線閱讀:https://www.rpcardio.com/jour/article/view/397
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍